KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Operating Leases (2019 - 2025)

Historic Operating Leases for Edwards Lifesciences (EW) over the last 7 years, with Q3 2025 value amounting to $75.3 million.

  • Edwards Lifesciences' Operating Leases fell 1141.18% to $75.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $75.3 million, marking a year-over-year decrease of 1141.18%. This contributed to the annual value of $78.9 million for FY2024, which is 1044.27% down from last year.
  • Per Edwards Lifesciences' latest filing, its Operating Leases stood at $75.3 million for Q3 2025, which was down 1141.18% from $78.7 million recorded in Q2 2025.
  • Edwards Lifesciences' 5-year Operating Leases high stood at $95.0 million for Q4 2022, and its period low was $63.5 million during Q2 2022.
  • Over the past 5 years, Edwards Lifesciences' median Operating Leases value was $74.2 million (recorded in 2024), while the average stood at $74.7 million.
  • As far as peak fluctuations go, Edwards Lifesciences' Operating Leases surged by 2142.86% in 2024, and later tumbled by 1141.18% in 2025.
  • Quarter analysis of 5 years shows Edwards Lifesciences' Operating Leases stood at $94.6 million in 2021, then increased by 0.42% to $95.0 million in 2022, then fell by 7.26% to $88.1 million in 2023, then dropped by 10.44% to $78.9 million in 2024, then decreased by 4.56% to $75.3 million in 2025.
  • Its Operating Leases stands at $75.3 million for Q3 2025, versus $78.7 million for Q2 2025 and $77.9 million for Q1 2025.